2m 2m 2m 2m 2m 2m 2m
ENTRADA THERAPET (TRDA)
NASDAQ
$4.74+$0.08 (+1.83%)
Price as of Oct 22, 2026 4:28 PM EDT- $181.1MMarket Cap
- -26.31%1-Year Change
- BiotechnologyIndustry
ENTRADA THERAPET (TRDA)
$4.74+$0.08 (+1.83%)
TRDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.65 | ||
Change | -$0.34 (-6.81%) | ||
Open | $5.02 | ||
High | $5.04 | ||
Low | $4.60 | ||
Previous Close | $4.99 | ||
Volume | 323,820 | ||
30-Day Average Volume | 366,446 | ||
1-Week Change | 2.20% | ||
1-Month Change | -29.97% | ||
1-Year Change | -26.31% | ||
3-Year Change | -68.41% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 38.9M | ||
Total Assets | $298.9M | ||
Market Cap | $181.1M | ||
Enterprise Value | $81.8M | ||
Period: QTR TTM FY | |||
Revenue | $898,000.00 | ||
Net Income | -$42.8M | ||
Free Cash Flow | -$32.5M | ||
EBIT | -$42.7M | ||
EBITDA | -$41.9M | ||
Net Working Capital | $211.3M | ||
EPS | -$1.01 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 91 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | 1 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue